Spero Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	78	78	90	518	527	184	112	169
Market Cap Growth	-	-13.02%	-82.69%	-1.83%	186.63%	64.43%	-33.75%	-
Enterprise Value	9	7	-13	378	408	107	-4	81
PE Ratio	3.42	3.42	-1.93	-5.77	-6.73	-3.02	-2.68	-3.66
PS Ratio	0.76	0.75	1.67	28.35	56.50	10.14	28.20	85.32
PB Ratio	0.74	0.73	1.18	5.86	3.99	2.47	0.97	2.00
P/FCF Ratio	-2.36	-2.36	-11.59	-8.04	-6.14	-3.65	-2.66	-4.31
P/OCF Ratio	-2.36	-2.36	-11.59	-8.04	-6.14	-3.68	-2.82	-4.32
EV/Sales Ratio	0.08	0.07	-0.24	20.73	43.74	5.92	-0.91	41.08
EV/EBITDA Ratio	0.33	0.28	0.30	-4.34	-5.26	-1.79	0.09	-2.12
EV/EBIT Ratio	0.34	0.28	0.29	-4.31	-5.21	-1.76	0.09	-2.10
EV/FCF Ratio	-0.22	-0.22	1.67	-5.88	-4.75	-2.13	0.09	-2.08
Debt / Equity Ratio	0.05	0.05	0.09	0.08	0.06	0.07	-	-
Debt / EBITDA Ratio	0.22	0.22	-0.15	-0.08	-0.10	-0.09	-	-
Debt / FCF Ratio	-0.17	-0.17	-0.86	-0.11	-0.09	-0.11	-	-
Quick Ratio	4.67	4.67	5.09	7.98	9.22	3.37	9.40	10.86
Current Ratio	3.53	3.53	5.25	8.46	9.70	3.58	10.08	11.29
Asset Turnover	0.83	0.83	0.54	0.13	0.07	0.16	0.04	0.04
Interest Coverage	-	-	-16.82	-45.27	-	-	-	-
Return on Equity (ROE)	32.60%	32.60%	-89.80%	-87.70%	-74.40%	-62.60%	-43.80%	-235.40%
Return on Assets (ROA)	18.20%	18.20%	-46.60%	-62.00%	-60.50%	-52.30%	-39.80%	-86.00%
Return on Capital (ROIC)	17.15%	17.15%	-51.10%	-92.00%	-56.56%	-78.90%	-37.06%	-49.33%
Earnings Yield	28.75%	29.27%	-51.82%	-17.34%	-14.85%	-33.13%	-37.25%	-27.30%
FCF Yield	-41.59%	-42.35%	-8.63%	-12.43%	-16.29%	-27.37%	-37.60%	-23.18%
Buyback Yield / Dilution	-40.98%	-40.98%	-21.65%	-38.01%	-23.27%	-13.49%	-518.58%	-728.67%
Total Shareholder Return	-40.98%	-40.98%	-21.65%	-38.01%	-23.27%	-13.49%	-518.58%	-728.67%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).